Skip to main content

Novartis AG

NVSEF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001114448

No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $6.28M in total; no superinvestor holds it.

Other share classesNVS

13F holders, Q1 2021

Institutional positions in Novartis AG as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
4
No complete 13F data for Q4 2020
Shares held
7.24M
No complete 13F data for Q4 2020
Total value
$620.9M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting NVSEF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 4 institutions
Q1 2021: 4 institutionsQ2 2021: 4 institutionsQ3 2021: 4 institutionsQ4 2021: 2 institutionsQ1 2022: 3 institutionsQ2 2022: 3 institutionsQ3 2022: 3 institutionsQ4 2022: 2 institutionsQ1 2023: 3 institutionsQ2 2023: 5 institutionsQ3 2023: 4 institutionsQ4 2023: 6 institutionsQ1 2024: 3 institutionsQ2 2024: 3 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 4 institutionsQ2 2025: 4 institutionsQ3 2025: 4 institutionsQ4 2025: 2 institutionsQ1 2026: 2 institutionsQ2 2026: 2 institutions
Value heldQ1 2021: $620.9M
Q1 2021: $620.9MQ2 2021: $392.5MQ3 2021: $3.07MQ4 2021: $3.09MQ1 2022: $3.32MQ2 2022: $35.0MQ3 2022: $33.6MQ4 2022: $42.1MQ1 2023: $57.0MQ2 2023: $72.8MQ3 2023: $71.1MQ4 2023: $70.4MQ1 2024: $18.8MQ2 2024: $33.2MQ3 2024: $26.3MQ4 2024: $20.1MQ1 2025: $36.0MQ2 2025: $31.1MQ3 2025: $23.9MQ4 2025: $6.82MQ1 2026: $6.85MQ2 2026: $6.28M
Institutions holding NVSEF and their total value by quarter
QuarterHoldersValue
Q2 20262$6.28M
Q1 20262$6.85M
Q4 20252$6.82M
Q3 20254$23.9M
Q2 20254$31.1M
Q1 20254$36.0M
Q4 20242$20.1M
Q3 20242$26.3M
Q2 20243$33.2M
Q1 20243$18.8M
Q4 20236$70.4M
Q3 20234$71.1M
Q2 20235$72.8M
Q1 20233$57.0M
Q4 20222$42.1M
Q3 20223$33.6M
Q2 20223$35.0M
Q1 20223$3.32M
Q4 20212$3.09M
Q3 20214$3.07M
Q2 20214$392.5M
Q1 20214$620.9M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Novartis AG.

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding NVSEF in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
ARK Investment Management LLCSuperinvestorARK Invest7,219,265$618.9M1.23%––
Cullen Capital Management LLC19,025$1.63M0.02%––
Diversified Trust Co3,800$325.0K0.01%––
IFP Advisors, Inc375$32.0K0.00%––